Arqule Inc (ARQL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | ARQL | SMMT | CORT | ||
Company | Arqule Inc | Summit Therapeu ADR | Corcept Therapeutics | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 20.00 | 3.52 | 22.47 | ||
High | 20.00 | 3.58 | 22.73 | ||
Low | 19.98 | 3.44 | 22.00 | ||
Last | 20.00 | 3.54 | 22.10 | ||
Change | +0.03 | -0.05 | -0.38 | ||
% Change | +0.15% | -1.39% | -1.69% | ||
Volume | 6,172,600 | 496,265 | 463,124 | ||
20-Day Average Volume | 4,217,200 | 1,749,214 | 1,001,228 | ||
Previous Close | 19.97 | 3.59 | 22.48 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 20.06 | 3.76 | 23.91 | ||
20-Day Raw Stochastic | 14.29% | 15.77% | 26.11% | ||
20-Day Relative Strength | 79.87% | 45.44% | 41.77% | ||
Weighted Alpha | +142.50 | +101.74 | -5.57 | ||
Today's Opinion | 88% Buy | 24% Buy | 88% Sell | ||
Previous Opinion | 88% Buy | 24% Buy | 88% Sell | ||
Last Month's Opinion | 100% Buy | 56% Buy | 40% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -0.10% since 01/08/20 | +1.00% since 04/18/24 | -1.97% since 04/18/24 | ||
Low | 19.97 on 01/14/20 | 3.34 on 04/19/24 | 20.84 on 04/22/24 | ||
High | 20.02 on 01/10/20 | 3.92 on 04/23/24 | 24.23 on 04/23/24 | ||
1-Month | |||||
%Chg | -0.32% since 12/13/19 | +8.08% since 03/25/24 | -9.92% since 03/25/24 | ||
Low | 19.93 on 01/02/20 | 3.34 on 04/19/24 | 20.84 on 04/22/24 | ||
High | 20.42 on 12/19/19 | 4.64 on 03/28/24 | 26.10 on 04/01/24 | ||
3-Month | |||||
%Chg | +131.62% since 10/15/19 | -22.09% since 01/25/24 | -3.25% since 01/25/24 | ||
Low | 6.98 on 11/06/19 | 3.25 on 03/22/24 | 20.84 on 04/22/24 | ||
High | 20.45 on 12/11/19 | 5.22 on 03/05/24 | 26.10 on 04/01/24 | ||
6-Month | |||||
%Chg | +88.68% since 07/15/19 | +88.56% since 10/25/23 | -19.25% since 10/25/23 | ||
Low | 6.79 on 09/30/19 | 1.64 on 11/09/23 | 20.84 on 04/22/24 | ||
High | 20.45 on 12/11/19 | 5.22 on 03/05/24 | 33.28 on 12/28/23 | ||
Key Statistics | |||||
Market Capitalization, $K | 2,417,460 | 2,519,114 | 2,339,786 | ||
Shares Outstanding, K | 120,873 | 701,703 | 104,083 | ||
Annual Sales | 25,760,000 | 0 | 482,380,000 | ||
Annual Net Income | -15,480,000 | -614,930,000 | 106,140,000 | ||
Last Quarter Sales | 210,000 | 0 | 135,410,000 | ||
Last Quarter Net Income | -10,740,000 | -36,570,000 | 31,360,000 | ||
60-Month Beta | 2.49 | -1.21 | 0.48 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.04 on 02/20/24 | 0.28 on 02/15/24 | ||
Latest Earnings Date | 03/05/20 | 05/09/24 | 05/01/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 24.21 |